U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Name Type Language
RIVABAZUMAB
INN  
INN  
Official Name English
rivabazumab [INN]
Common Name English
IMMUNOGLOBULIN, ANTI-(PSEUDOMONAS AERUGINOSA PROTEIN PCRV) FAB' FRAGMENT (SYNTHETIC HUMAN MONOCLONAL BA1126 HEAVY CHAIN), COMPD. WITH SYNTHETIC HUMAN MONOCLONAL BA1126 LIGHT CHAIN
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C52588
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
Code System Code Type Description
INN
10197
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
PRIMARY
NCI_THESAURUS
C152235
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
PRIMARY
CAS
1627519-84-9
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
PRIMARY
FDA UNII
QBH6ZCM7NF
Created by admin on Sat Dec 16 11:18:15 UTC 2023 , Edited by admin on Sat Dec 16 11:18:15 UTC 2023
PRIMARY
ACTIVE MOIETY
RIVABAZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966